Hostpathogen specificity in Tuberculosis

Advances in Experimental Medicine and Biology

Volumn 783, Issue , 2013, Pages 33-44

  Di Pietrantonio, Tania ^a   Schurr, Erwin ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

ANOVA; Autophagy; BCG infection; Chemokine and chemokine related genes; Hostpathogen specificity; Mannose binding lectin (MBL); Meningeal Tuberculosis; Mycobacterium Tuberculosis; Pathogen associated molecular patterns; Phagosome maturation; RC strains; Toll like receptors

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; GUANOSINE TRIPHOSPHATASE; IMMUNITY RELATED GTPASE M; MANNOSE BINDING LECTIN 2; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IRGM PROTEIN, HUMAN; MANNOSE BINDING LECTIN; MBL2 PROTEIN, HUMAN; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; TLR2 PROTEIN, HUMAN;

ARTICLE; BACTERIAL STRAIN; CASE CONTROL STUDY; ETHNIC GROUP; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; HAPLOTYPE; HEREDITY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; TUBERCULOSIS; ANIMAL; ETHNOLOGY; GENETIC PREDISPOSITION; HEALTH; HOST RANGE; IMMUNOLOGY; MICROBIOLOGY; MOUSE; MOUSE STRAIN; MYCOBACTERIUM BOVIS; PATHOGENICITY; PHYSIOLOGY; REVIEW; SPECIES DIFFERENCE;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CATION TRANSPORT PROTEINS; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GTP-BINDING PROTEINS; HOST SPECIFICITY; HUMANS; MANNOSE-BINDING LECTIN; MICE; MICE, INBRED STRAINS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY; TOLL-LIKE RECEPTOR 2; TUBERCULOSIS; WORLD HEALTH;

MLCS; MLOWN;

EID: 84879515960     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-6111-1_2     Document Type: Article

References (61)

1. Rieder HL (1999) Epidemiologic basis of Tuberculosis control. International Union Against Tuberculosis and Lung Disease, Paris, p 166
2. Stead WW (1992) Genetics and resistance to Tuberculosis. Could resistance be enhanced by genetic engineering? Ann Intern Med 116(11):937-941
3. Stead WW, Senner JW, Reddick WT, Lofgren JP (1990) Racial differences in susceptibility to infection by Mycobacterium Tuberculosis. N Engl J Med 322(7):422-427
4. Comstock GW (1978) Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 117(4):621-624
5. Kallman FJ, Reisner D (1943) Twin studies on the significance of genetic factors in Tuberculosis. Am Rev Tuberc 47:549-574
6. Boisson-Dupuis S, El Baghdadi J, Parvaneh N, Bousfiha A, Bustamante J, Feinberg J et al (2011) IL-12Rbeta1 deficiency in two of fifty children with severe Tuberculosis from Iran, Morocco, and Turkey. PLoS One 6(4):e18524
7. Sologuren I, Boisson-Dupuis S, Pestano J, Vincent QB, Fernandez-Perez L, Chapgier A et al (2011) Partial recessive IFN-gammaR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum Mol Genet 20(8):1509-1523
8. Mahasirimongkol S, Yanai H, Nishida N, Ridruechai C, Matsushita I, Ohashi J et al (2009) Genome-wide SNP-based linkage analysis of Tuberculosis in Thais. Genes Immun 10(1):77-83
9. Baghdadi JE, Orlova M, Alter A, Ranque B, Chentoufi M, Lazrak F et al (2006) An autosomal dominant major gene confers predisposition to pulmonary Tuberculosis in adults. J Exp Med 203(7):1679-1684
10. Stein CM, Zalwango S, Malone LL, Won S, Mayanja-Kizza H, Mugerwa RD et al (2008) Genome scan of M. Tuberculosis infection and disease in Ugandans. PLoS ONE 3(12):e4094
11. Cooke GS, Campbell SJ, Bennett S, Lienhardt C, McAdam KP, Sirugo G et al (2008) Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human Tuberculosis. Am J Respir Crit Care Med 178(2):203-207
12. Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ, Howson JM et al (2004) Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to Tuberculosis and leprosy in Brazilians. Genes Immun 5(1):46-57
13. Miller EN, Jamieson SE, Joberty C, Fakiola M, Hudson D, Peacock CS et al (2004) Genomewide scans for leprosy and Tuberculosis susceptibility genes in Brazilians. Genes Immun 5(1):63-67
14. Bellamy R, Beyers N, McAdam KP, Ruwende C, Gie R, Samaai P et al (2000) Genetic susceptibility to Tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci USA 97(14):8005-8009
15. Mahasirimongkol S, Yanai H, Mushiroda T, Promphittayarat W, Wattanapokayakit S, Phromjai J et al (2012) Genome-wide association studies of Tuberculosis in Asians identify distinct at-risk locus for young Tuberculosis. J Hum Genet 57(6):363-367
16. Thye T, Owusu-Dabo E, Vannberg FO, van Crevel R, Curtis J, Sahiratmadja E et al (2012) Common variants at 11p13 are associated with susceptibility to Tuberculosis. Nat Genet 44(3):257-259
17. Moller M, de Wit E, Hoal EG (2010) Past, present and future directions in human genetic susceptibility to Tuberculosis. FEMS Immunol Med Microbiol 58(1):3-26
18. Stein CM (2011) Genetic epidemiology of Tuberculosis susceptibility: impact of study design. PLoS Pathog 7(1):e1001189
19. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, Ritacco V et al (2003) A marked difference in pathogenesis and immune response induced by different Mycobacterium Tuberculosis genotypes. Clin Exp Immunol 133(1):30-37
20. Manca C, Tsenova L, Barry CE 3rd, Bergtold A, Freeman S, Haslett PA et al (1999) Mycobacterium Tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 162(11):6740-6746
21. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM et al (2001) Virulence of a Mycobacterium Tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci USA 98(10):5752-5757
22. Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN et al (2004) A glycolipid of hypervirulent Tuberculosis strains that inhibits the innate immune response. Nature 431(7004):84-87
23. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, Thuong NT et al (2008) The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium Tuberculosis. PLoS Pathog 4(3):e1000034
24. Gagneux S, Small PM (2007) Global phylogeography of Mycobacterium Tuberculosis and implications for Tuberculosis product development. Lancet Infect Dis 7(5):328-337
25. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S et al (2006) Variable host-pathogen compatibility in Mycobacterium Tuberculosis. Proc Natl Acad Sci USA 103(8):2869-2873
26. Reed MB, Pichler VK, McIntosh F, Mattia A, Fallow A, Masala S et al (2009) Major Mycobacterium Tuberculosis lineages associate with patient country of origin. J Clin Microbiol 47(4):1119-1128
27. Wirth T, Hildebrand F, Allix-Beguec C, Wolbeling F, Kubica T, Kremer K et al (2008) Origin, spread and demography of the Mycobacterium Tuberculosis complex. PLoS Pathog 4(9):e1000160
28. Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM (2004) Stable association between strains of Mycobacterium Tuberculosis and their human host populations. Proc Natl Acad Sci USA 101(14):4871-4876
29. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, Homolka S et al (2008) High functional diversity in Mycobacterium Tuberculosis driven by genetic drift and human demography. PLoS Biol 6(12):e311
30. Medina E, North RJ (1996) Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium Tuberculosis. J Exp Med 183(3):1045-1051
31. Medina E, North RJ (1998) Resistance ranking of some common inbred mouse strains to Mycobacterium Tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 93(2):270-274
32. Actor JK, Olsen M, Jagannath C, Hunter RL (1999) Relationship of survival, organism containment, and granuloma formation in acute murine Tuberculosis. J Interferon Cytokine Res 19(10):1183-1193
33. Jagannath C, Hoffmann H, Sepulveda E, Actor JK, Wetsel RA, Hunter RL (2000) Hypersusceptibility of A/J mice to Tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand J Immunol 52(4):369-379
34. Watson VE, Hill LL, Owen-Schaub LB, Davis DW, McConkey DJ, Jagannath C et al (2000) Apoptosis in Mycobacterium Tuberculosis infection in mice exhibiting varied immunopathology. J Pathol 190(2):211-220
35. Gros P, Skamene E, Forget A (1981) Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 127(6):2417-2421
36. Vidal SM, Malo D, Vogan K, Skamene E, Gros P (1993) Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73(3):469-485
37. Di Pietrantonio T, Correa JA, Orlova M, Behr MA, Schurr E (2011) Joint effects of host genetic background and mycobacterial pathogen on susceptibility to infection. Infect Immun 79(6):2372-2378
38. Woolhouse ME, Webster JP, Domingo E, Charlesworth B, Levin BR (2002) Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat Genet 32(4):569-577
39. Kramnik I, Dietrich WF, Demant P, Bloom BR (2000) Genetic control of resistance to experimental infection with virulent Mycobacterium Tuberculosis. Proc Natl Acad Sci USA 97(15):8560-8565
40. Lavebratt C, Apt AS, Nikonenko BV, Schalling M, Schurr E (1999) Severity of Tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J Infect Dis 180(1):150-155
41. Mitsos LM, Cardon LR, Fortin A, Ryan L, LaCourse R, North RJ et al (2000) Genetic control of susceptibility to infection with Mycobacterium Tuberculosis in mice. Genes Immun 1(8):467-477
42. Mitsos LM, Cardon LR, Ryan L, LaCourse R, North RJ, Gros P (2003) Susceptibility to Tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium Tuberculosis replication in the lungs. Proc Natl Acad Sci USA 100(11):6610-6615
43. Sanchez F, Radaeva TV, Nikonenko BV, Persson AS, Sengul S, Schalling M et al (2003) Multigenic control of disease severity after virulent Mycobacterium Tuberculosis infection in mice. Infect Immun 71(1):126-131
44. Di Pietrantonio T, Hernandez C, Girard M, Verville A, Orlova M, Belley A et al (2010) Strain-specific differences in the genetic control of two closely related mycobacteria. PLoS Pathog 6(10):e1001169
45. McInturff JE, Modlin RL, Kim J (2005) The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 125(1):1-8
46. Tsenova L, Ellison E, Harbacheuski R, Moreira AL, Kurepina N, Reed MB et al (2005) Virulence of selected Mycobacterium Tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis 192(1):98-106
47. Constant P, Perez E, Malaga W, Laneelle MA, Saurel O, Daffe M et al (2002) Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium Tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J Biol Chem 277(41):38148-38158
48. Malo D, Vogan K, Vidal S, Hu J, Cellier M, Schurr E et al (1994) Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23(1):51-61
49. Hackam DJ, Rotstein OD, Zhang W, Gruenheid S, Gros P, Grinstein S (1998) Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J Exp Med 188(2):351-364
50. Gallant CJ, Malik S, Jabado N, Cellier M, Simkin L, Finlay BB et al (2007) Reduced in vitro functional activity of human NRAMP1 (SLC11A1) allele that predisposes to increased risk of pediatric Tuberculosis disease. Genes Immun 8(8):691-698
51. van Crevel R, Parwati I, Sahiratmadja E, Marzuki S, Ottenhoff TH, Netea MG et al (2009) Infection with Mycobacterium Tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with Tuberculosis. J Infect Dis 200(11):1671-1674
52. Deretic V, Levine B (2009) Autophagy, immunity, and microbial adaptations. Cell Host Microbe 5(6):527-549
53. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium Tuberculosis survival in infected macrophages. Cell 119(6):753-766
54. Singh SB, Davis AS, Taylor GA, Deretic V (2006) Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313(5792):1438-1441
55. Intemann CD, Thye T, Niemann S, Browne EN, Amanua Chinbuah M, Enimil A et al (2009) Autophagy gene variant IRGM -261T contributes to protection from Tuberculosis caused by Mycobacterium Tuberculosis but not by M. africanum strains. PLoS Pathog 5(9):e1000577
56. Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A (2002) Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nature Immunol 3(1):76-82
57. Parkinson JF (2006) Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation. Inflamm Allergy Drug Targets 5(2):91-106
58. Hachicha M, Pouliot M, Petasis NA, Serhan CN (1999) Lipoxin (LX)A4 and aspirintriggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J Exp Med 189(12):1923-1930
59. Herb F, Thye T, Niemann S, Browne EN, Chinbuah MA, Gyapong J et al (2008) ALOX5 variants associated with susceptibility to human pulmonary Tuberculosis. Hum Mol Genet 17(7):1052-1060
60. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW (2000) Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68(2):688-693
61. Thye T, Niemann S, Walter K, Homolka S, Intemann CD, Chinbuah MA et al (2011) Variant G57E of mannose binding lectin associated with protection against Tuberculosis caused by Mycobacterium africanum but not by M. Tuberculosis. PLoS One 6(6):e20908